Indefinite Delivery Contract 36E79725D0027

Award Date 6/23/25
Last Date to Order 6/22/26
Awardee
Avkare LLC
Ultimate Awardee
Not listed
Federal Contract Vehicle
Pricing Type
Firm Fixed Price
Legislative Mandate
Not listed
National Interest Action
None
Award Type
Single
Primary Consortia Member
Not listed
Similar IDVs
This Indefinite Delivery Contract (IDC) was awarded by the VA National Acquisition Center to Avkare, LLC, a pharmaceutical and medical supply company based in Pulaski, Tennessee. The contract has a ceiling value of $1,244,773.20 and a performance period from July 15, 2024 to July 14, 2025, with four one-year option periods. The contract aims to provide a wide range of pharmaceutical and medical products to support the healthcare missions of the Department of Veterans Affairs (VA), Department...
This Indefinite Delivery Contract (IDC) was awarded by the Department of Veterans Affairs (VA) National Acquisition Center to Golden State Medical Supply, Inc., a for-profit manufacturer and distributor of pharmaceuticals and medical products. The contract has a ceiling value of $8,612,710.75 and covers the supply of mycophenolic acid tablets in 180mg and 360mg strengths to the VA, Department of Defense (DoD), Bureau of Prisons (BOP), and Indian Health Service (IHS). This single-award IDC has...
This indefinite delivery contract (IDC) was awarded by the National Acquisition Center, a civilian federal agency, to Avkare LLC, a pharmaceutical and medical supply company, to provide a wide range of pharmaceutical products to the Department of Veterans Affairs (VA), Department of Defense (DoD), Bureau of Prisons (BOP), and Indian Health Service (IHS). The contract has a total ceiling value of $12,991,472.85 and a period of performance from March 16, 2020 to March 15, 2025. It was awarded as a...
This Indefinite Delivery Contract (IDC) was awarded by the Defense Logistics Agency (DLA) to Avkare LLC, a pharmaceutical and medical supply company based in Pulaski, Tennessee. The contract has a ceiling value of $16,701,923.95 and a period of performance through December 7, 2026. The contract is for the manufacture and distribution of pharmaceutical and medical supplies, primarily generic medications such as cephalexin, prednisone, emtricitabine-tenofovir, primaquine phosphate, and...
This Indefinite Delivery Contract (IDC) awarded by the Defense Logistics Agency (DLA) to Avkare LLC, a pharmaceutical and medical supply company, has a total ceiling value of $10,373,182.60. The contract is for the manufacture and distribution of various pharmaceutical and medical products, including generic medications such as cephalexin, prednisone, sulfamethoxazole-trimethoprim, and primaquine phosphate tablets, as well as medical equipment and supplies like urinalysis testing materials and...
This indefinite delivery contract was awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Avkare LLC, a pharmaceutical and medical supply company based in Pulaski, Tennessee. The contract has a ceiling value of $4,897,608.76 and a period of performance through March 7, 2033. The contract aims to procure a wide range of pharmaceutical products and medical supplies to support the healthcare missions of various federal agencies, including the Department of Veterans Affairs...
This Indefinite Delivery Contract (IDC) was awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Avkare LLC, a pharmaceutical and medical supply company based in Tennessee. The $62,144,789.65 contract has a period of performance through April 2025 and allows the DLA, Department of Veterans Affairs (VA), Indian Health Service (IHS), and Bureau of Prisons (BOP) to issue task orders for a variety of pharmaceutical and medical products. The original solicitation sought offers for a...
This indefinite delivery contract (IDC) was awarded by the Department of Veterans Affairs (VA) National Acquisition Center to Avkare LLC, a for-profit limited liability company based in Pulaski, Tennessee. The contract, valued at $4,619,331.60, is for the supply of phenytoin sodium extended-release capsules to the VA, Department of Defense (DoD), Bureau of Prisons (BOP), and Indian Health Service (IHS). The contract has a one-year base period with four one-year option periods, and allows the...
The Indefinite Delivery Contract (IDC) SPE2D222D0144 was awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Avkare LLC, a pharmaceutical and medical supply company based in Pulaski, Tennessee. The single-award contract has a ceiling value of $14,460,136.05 and a period of performance through May 3, 2027. Under this IDC, Avkare will manufacture and distribute a variety of pharmaceutical and medical products, including generic drugs such as cephalexin, prednisone,...
This Indefinite Delivery Contract (IDC) award from the Defense Logistics Agency (DLA) to Avkare LLC, a for-profit limited liability company based in Pulaski, Tennessee, has a ceiling value of $3,798,662.40 and a period of performance through April 26, 2025. The contract is for the manufacture and distribution of pharmaceutical and medical products, primarily consisting of generic medications such as cephalexin, prednisone, emtricitabine-tenofovir, primaquine phosphate, and...

This Indefinite Delivery Contract (IDC) was awarded by the Department of Veterans Affairs (VA) National Acquisition Center to Avkare LLC, a pharmaceutical and medical supply company based in Pulaski, Tennessee. The contract has a ceiling value of $24,898,277.30 and a period of performance from June 23, 2025 to June 22, 2026.

The contract is for the supply of Mycophenolate Mofetil capsules and tablets to the VA, Department of Defense, Bureau of Prisons, and Indian Health Service. The estimated annual requirements include 18,706 bottles of 250mg capsules in 100-count, 17,378 bottles of 250mg capsules in 500-count, 7,307 bottles of 500mg tablets in 100-count, and 18,281 bottles of 500mg tablets in 500-count. This procurement is unrestricted, and the contract will be distributed through the VA's and Department of Defense's respective Pharmaceutical Prime Vendor Programs. Offerors must provide products with exact labeling names and unique National Drug Codes (NDCs), and all bottles containing 100 tablets or less must have child-resistant closures, with glass bottles explicitly prohibited.

Generated 4/27/25, 12:49 AM